rural health

Digital

As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in

News

AstraZeneca's Calquence and AbbVie/Roche's Venclexta have become the first all-oral, fixed-duration regimen for newly-diagnosed CLL.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.